12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2022-08-15), Perrigo Co's 12-1 Month Momentum % is 1.31%.
The industry rank for Perrigo Co's 12-1 Month Momentum % or its related term are showing as below:
PRGO's 12-1 Month Momentum % is ranked better than 76.45% of 1121
companies
in the Drug Manufacturers industry
Industry Median: -26.44
vs PRGO: 1.31
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co 12-1 Month Momentum % Distribution
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's 12-1 Month Momentum % falls into.
Perrigo Co (NYSE:PRGO) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (NYSE:PRGO) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Perrigo Co 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Perrigo Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.24(0.57%) Volume: 359,102 2:45PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:PRGO has been successfully added to your 
